Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan
Author:
Funder
JSPS KAKENHI
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,General Medicine,Pathology and Forensic Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00795-020-00273-3.pdf
Reference46 articles.
1. Pursell ZF, Isoz I, Lundström EB, Johansson E, Kunkel TA (2007) Yeast DNA polymerase epsilon participates in leading-strand DNA replication. Science 317:127–130
2. Castellucci E, He T, Goldstein DY, Halmos B, Chuy J (2017) DNA polymerase ε deficiency leading to an ultramutator phenotype: a novel clinically relevant entity. Oncologist 22:497–502
3. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497:67–73
4. Church DN, Briggs SE, Palles C, Domingo E, Kearsey SJ, Grimes JM, Gorman M, Martin L, Howarth KM, Hodgson SV, Collaborators NSECG, Kaur K, Taylor J, Tomlinson IP (2013) DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Hum Mol Genet 22:2820–2828
5. Meng B, Hoang LN, McIntyre JB, Duggan MA, Nelson GS, Lee CH, Köbel M (2014) POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium. Gynecol Oncol 134:15–19
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Morphomolecular Correlation and Clinicopathologic Analysis in Endometrial Carcinoma;International Journal of Gynecological Pathology;2024-07-08
2. Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis;Gynecologic Oncology;2024-03
3. Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes;JNCI: Journal of the National Cancer Institute;2022-04-27
4. Molecular Pathology and Clinicopathological Significance of Endometrial Carcinoma;Current Human Cell Research and Applications;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3